References
- 1. Martinez AI, Freeman PR, Moga DC. Statin Use and Gastrointestinal Hemorrhage: A Large Retrospective Cohort Study. Am J Cardiovasc Drugs. 2018 Sep 26. doi: 10.1007/s40256-018-0301-4. [Epub ahead of print]10.1007/s40256-018-0301-4.[Epubaheadprint
- 2. Smith I, Schmidt R, Halm EA, Mansi IA. Do Statins Increase the Risk of Esophageal Conditions? Findings from Four Propensity Score-Matched Analyses. Clin Drug Investig. 2018;38:135-146.
- 3. Kuoppala J, Lamminpaa A, Pukkala E. Statins and cancer: A systematic review and meta-analysis. Eur J Cancer. 2008;44:2122-2132.
- 4. Browning DR, Martin RM. Statins and the risk of cancer: A systematic review and metanalysis. Int J Cancer. 2007;120:833-843.
- 5. Badillo R, Schmidt R, Mortensen EM, Frei CR, Mansi I. Statin therapy and gastrointestinal hemorrhage: a retrospective cohort study with propensity score-matching. Pharmacoepidemiol Drug Saf. 2015;24:849-857.
- 6. Joo MK, Park JJ, Chun HJ. Additional Benefits of Routine Drugs on Gastrointestinal Cancer: Statins, Metformin, and Proton Pump Inhibitors. Dig Dis. 2018;36:1-14.
- 7. Negovan A, Iancu M, Moldovan V, et al. The contribution of clinical and pathological predisposing factors to severe gastro-duodenal lesions in patients with low dose aspirin and proton pump inhibitor therapy. Eur J Intern Med. 2017;44:62-66.
- 8. Park YH, Kim N. Review of atrophic gastritis and intestinal metaplasia as a premalignant lesion of gastric cancer. J Cancer Prev. 2015;20:25-40.
- 9. Cheung KS, Leung WK. Risk of gastric cancer development after eradication of Helicobacter pylori. World J Gastrointest Oncol. 2018;10:115-123.
- 10. Cheung KS, Chan EW, Wong AY, Chen L, Wong ICK, Leung WK. Long-term proton pump inhibitors and risk of gastric cancer development after treatment for Helicobacter pylori: a population based study. Gut. 2018;67:28-35.
- 11. Yoom H, Kim N. Diagnosis and management of high risk group for gastric cancer. Gut Liver. 2015;9:5-17.
- 12. Wang WH, Huang JQ, Zheng GF, Lam SK, Karlberg J, Wong BC. Nonsteroidal anti-inflammatory drug use and the risk of gastric cancer: a systematic review and meta-analysis. J Natl Cancer Inst. 2003;95:1784-1791.
- 13. Algra AM, Rothwell PM. Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomized trials. Lancet Oncol. 2012;13:518-527.
- 14. Emberson JR, Kearny PM, Blackwell L, et al. Cholesterol Treatment Trialists’ (CTT) Collaboration. Lack of effect of lowering LDL cholesterol on cancer. Meta-analysis of individual data from 175.000 people in 27 randomized trials of statin therapy. PLoS One. 2012;7:e29849.
- 15. Shimoyama S. Statins and gastric cancer risk. Hepatology. 2011;58:1057-1061.
- 16. Chiu HF, Ho SC, Chang CC, Wu TN, Yang CY. Statins are associated with a reduced risk of gastric cancer: A population-based case-control study. Am J Gastroenterol. 2011;106:2098-2103.
- 17. Leung HW, Chan AL, Lo D, Leung JH, Chen HL. Common cancer risk and statins: A population-based case-control study in a Chinese population. Expert Opinion on Drug Safety. 2013;12:19-27.
- 18. Ma Z, Wang W, Jin G, Chu P, Li H. Effect of statins on gastric cancer incidence: a meta-analysis of case control studies. J Cancer Res Ther. 2014;10:859-865.
- 19. Negovan A, Iancu M, Moldovan V, Mocan S, Banescu C. The Interaction between GSTT1, GSTM1, and GSTP1 Ile105Val Gene Polymorphisms and Environmental Risk Factors in Premalignant Gastric Lesions Risk. Biomed Res Int. 2017;2017:7365080.